Panminerva medica最新文献

筛选
英文 中文
The impact of the application of Internet technology on improving the efficiency of medical care integration management. 互联网技术应用对提高医疗一体化管理效率的影响。
IF 4.3 4区 医学
Panminerva medica Pub Date : 2025-03-01 Epub Date: 2023-07-18 DOI: 10.23736/S0031-0808.23.04936-4
Huaiying Shi, Yichen Zhang, Xing Wang, Lijun Wu, Xun Gong, Xuanxuan Wang
{"title":"The impact of the application of Internet technology on improving the efficiency of medical care integration management.","authors":"Huaiying Shi, Yichen Zhang, Xing Wang, Lijun Wu, Xun Gong, Xuanxuan Wang","doi":"10.23736/S0031-0808.23.04936-4","DOIUrl":"10.23736/S0031-0808.23.04936-4","url":null,"abstract":"","PeriodicalId":19851,"journal":{"name":"Panminerva medica","volume":" ","pages":"52-54"},"PeriodicalIF":4.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9882629","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deprescription of benzodiazepines and its management according to an overlapping strategy with a low-dose multicomponent medication: a Delphi consensus. 苯二氮卓类药物的解处方及其管理与低剂量多组分药物重叠策略:德尔菲共识。
IF 4.3 4区 医学
Panminerva medica Pub Date : 2025-03-01 DOI: 10.23736/S0031-0808.25.05330-3
Rocco Melcarne, Sergio Bernasconi, Marco Del Prete, Spartaco Artizzu, Susanna Guttmann, Giorgio Ciprandi, Angelo Gemignani
{"title":"Deprescription of benzodiazepines and its management according to an overlapping strategy with a low-dose multicomponent medication: a Delphi consensus.","authors":"Rocco Melcarne, Sergio Bernasconi, Marco Del Prete, Spartaco Artizzu, Susanna Guttmann, Giorgio Ciprandi, Angelo Gemignani","doi":"10.23736/S0031-0808.25.05330-3","DOIUrl":"https://doi.org/10.23736/S0031-0808.25.05330-3","url":null,"abstract":"<p><strong>Background: </strong>About 20% of adults and between 6% and 13% of children experience mild to moderate anxiety and stress-related symptoms. Benzodiazepines (BZDs) are considered the referring medications for early-stage anxiety and stress-related symptoms management. Nevertheless, BZDs must be managed carefully because their use, especially chronic, could be linked with some adverse effects, and can promote the onset of psychological and physical dependence. They also often show progressive tolerance, necessitating an increase in dosage, and therefore their use should be discouraged. In the clinical management of patients with pathological/dysfunctional anxiety, one of the main issues related to the discontinuation of BZDs treatment is the occurrence of rebound effects and withdrawal syndrome, especially in subjects with certain personality disorders and poly-drug users. The deprescription of BZDs is advisable with the availability of other therapies and interventions, especially in elderly subjects. Therefore, an effective and safe alternative pharmacological tool for mild to moderate anxiety and stress-related symptoms is needed. After the identification of potentially new medications to flank BZDs, it is mandatory to revise and improve good clinical practices even through a consensus process.</p><p><strong>Methods: </strong>Taking into consideration all the above-mentioned premises, the present Delphi Consensus Study has explored whether there is agreement about the use of the low-dose multicomponent natural medication Ignatia-Heel in overlapping with BZDs is appropriate for the reduction and potential discontinuation of BZDs intake in patients on chronic BZDs treatment.</p><p><strong>Results: </strong>The Consensus Study also explored the possibility to maintain symptom remission or low disease activity with the long-term use of Ignatia-Heel in patients with pathological/dysfunctional anxiety, after clinical remission achieved with BZDs. For each questionnaire statement, consensus was achieved (being based on the agreement of at least 66.6% of the Consensus Panel and the acceptance of the scientific committee).</p><p><strong>Conclusions: </strong>Ignatia-Heel can be considered a valid opportunity for the treatment of pathological anxiety favoring the deprescription of BZDs in patients under chronic BZDs treatment and the maintenance of a good control of symptomatology, i.e., a good low disease activity.</p>","PeriodicalId":19851,"journal":{"name":"Panminerva medica","volume":"67 1","pages":"14-26"},"PeriodicalIF":4.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144079413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Results of AIPO Italian survey on sustainability in Interventional Pulmonology. 意大利AIPO介入肺科可持续性调查结果。
IF 4.3 4区 医学
Panminerva medica Pub Date : 2025-03-01 Epub Date: 2025-04-08 DOI: 10.23736/S0031-0808.25.05279-6
Filippo Patrucco, Alberto Fantin, Alessandro Di Marco Berardino, Maria Majori, Roberto Piro, Valentina Pinelli, Silvia Puglisi, Elena Tagliabue, Marco Trigiani, Rocco F Rinaldo, Paolo Solidoro, Emanuela Barisione
{"title":"Results of AIPO Italian survey on sustainability in Interventional Pulmonology.","authors":"Filippo Patrucco, Alberto Fantin, Alessandro Di Marco Berardino, Maria Majori, Roberto Piro, Valentina Pinelli, Silvia Puglisi, Elena Tagliabue, Marco Trigiani, Rocco F Rinaldo, Paolo Solidoro, Emanuela Barisione","doi":"10.23736/S0031-0808.25.05279-6","DOIUrl":"10.23736/S0031-0808.25.05279-6","url":null,"abstract":"<p><strong>Background: </strong>Sustainability in medicine is gaining increasing importance. In interventional pulmonology only few studies demonstrated the impact of mechanisms involved in CO<inf>2</inf> equivalent production; moreover, operators' sensitivity to sustainability and each center's recycling processes are highly variable. We conducted a national survey among interventional pulmonologists on perception of sustainability resulting from their work, and how endoscopic activity impacts the production of recyclable material.</p><p><strong>Methods: </strong>A 26-item questionnaire was sent to each AIPO member registered in the interventional pulmonology study group. Items were divided in four topics: demographic data, perception of the problem, measures in place to improve sustainability and potentially feasible measure to improve the problem.</p><p><strong>Results: </strong>We obtained a 16.2% response rate and majority of participants work in high volume centers. Climate change was perceived as an important problem but responders though that physicians are few involved mainly due to lack of awareness of the problem. Recycling programs are widely available with differentiation between recyclable and potentially contaminated material. The disposable bronchoscopes use was perceived to increase carbon footprint. Most critical interventions to improve sustainability suggested were: optimization of separate waste collection, instrument reprocessing procedures, adherence to guidelines to reduce unnecessary procedures and improving staff awareness. Most participants believed that scientific societies should establish a working group on climate change.</p><p><strong>Conclusions: </strong>The sustainability of daily activity in interventional pulmonology is a cause for concern among interventional pulmonologists while the lack of awareness remains the main reason for the poor perception of the problem; sustainability represents a need and an opportunity for interventional pulmonologists to align with other disciplines, but this concept can also be extended to all areas of pneumology.</p>","PeriodicalId":19851,"journal":{"name":"Panminerva medica","volume":" ","pages":"10-13"},"PeriodicalIF":4.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143803938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Critical gene screening and prognostic analysis of differential genes associated with non-small cell lung cancer. 非小细胞肺癌相关差异基因的关键基因筛选及预后分析
IF 4.3 4区 医学
Panminerva medica Pub Date : 2025-03-01 Epub Date: 2023-10-25 DOI: 10.23736/S0031-0808.23.04973-X
Chuner Lv, Ruibing Zheng, Mengxi Li
{"title":"Critical gene screening and prognostic analysis of differential genes associated with non-small cell lung cancer.","authors":"Chuner Lv, Ruibing Zheng, Mengxi Li","doi":"10.23736/S0031-0808.23.04973-X","DOIUrl":"10.23736/S0031-0808.23.04973-X","url":null,"abstract":"","PeriodicalId":19851,"journal":{"name":"Panminerva medica","volume":" ","pages":"56-58"},"PeriodicalIF":4.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"50158522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Urinary stones complicated with novel coronavirus pneumonia after lung cancer surgery. 癌症手术后尿路结石合并新型冠状病毒肺炎。
IF 4.3 4区 医学
Panminerva medica Pub Date : 2025-03-01 Epub Date: 2023-09-21 DOI: 10.23736/S0031-0808.23.04938-8
Xiaojuan Li, Yanping Cao, Pengbo Yin, Hongxu Zhang
{"title":"Urinary stones complicated with novel coronavirus pneumonia after lung cancer surgery.","authors":"Xiaojuan Li, Yanping Cao, Pengbo Yin, Hongxu Zhang","doi":"10.23736/S0031-0808.23.04938-8","DOIUrl":"10.23736/S0031-0808.23.04938-8","url":null,"abstract":"","PeriodicalId":19851,"journal":{"name":"Panminerva medica","volume":" ","pages":"54-55"},"PeriodicalIF":4.3,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41129359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correlation analysis of clinical characteristics of patients with postpartum hemorrhage. 产后出血患者临床特征的相关性分析。
IF 4.3 4区 医学
Panminerva medica Pub Date : 2024-12-10 DOI: 10.23736/S0031-0808.24.05045-6
Jiyun Li, Hong Cui, Jing Chen
{"title":"Correlation analysis of clinical characteristics of patients with postpartum hemorrhage.","authors":"Jiyun Li, Hong Cui, Jing Chen","doi":"10.23736/S0031-0808.24.05045-6","DOIUrl":"https://doi.org/10.23736/S0031-0808.24.05045-6","url":null,"abstract":"","PeriodicalId":19851,"journal":{"name":"Panminerva medica","volume":" ","pages":""},"PeriodicalIF":4.3,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142802033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EGFR T790M mutation detection in NSCLC patients resistant to tyrosine kinase inhibitor therapy. 检测对酪氨酸激酶抑制剂治疗耐药的 NSCLC 患者的表皮生长因子受体 T790M 突变。
IF 4.3 4区 医学
Panminerva medica Pub Date : 2024-12-01 Epub Date: 2024-09-27 DOI: 10.23736/S0031-0808.24.05172-3
Rabiga Kadyrbayeva, Dilyara Kaidarova, Oxana Shatkovskaya, Tatyana Goncharova, Madina Orazgalieva, Saniya Ossikbayeva
{"title":"EGFR T790M mutation detection in NSCLC patients resistant to tyrosine kinase inhibitor therapy.","authors":"Rabiga Kadyrbayeva, Dilyara Kaidarova, Oxana Shatkovskaya, Tatyana Goncharova, Madina Orazgalieva, Saniya Ossikbayeva","doi":"10.23736/S0031-0808.24.05172-3","DOIUrl":"10.23736/S0031-0808.24.05172-3","url":null,"abstract":"<p><strong>Background: </strong>The finding of mutations that activate epidermal growth factor receptor (EGFR) in people with lung adenocarcinoma resulted in the creation of a new class of biological treatments called tyrosine kinase inhibitors (TKI). These medications have changed how patients with EGFR mutations are clinically managed, nearly doubling their survival rate compared to standard chemotherapy. Though 1st and 2nd generation EGFR TKIs are initially highly effective, typically within 9-14 months all tumors with the mutation progress due to secondary resistance mutations involving alternative molecular pathways. In most cases (up to 60%), this is due to the T790M mutation emerging in the EGFR gene.</p><p><strong>Methods: </strong>The study included 85 patients with NSCLC with progression of the disease after treatment with TKI 1st and 2nd generation. The T790M mutation was determined by digital polymerase chain reaction (PCR) on the QIAcuity One 5plex digital PCR system and traditional real-time PCR. Real-time PCR analysis of the presence of the T790M mutation was performed using the Therascreen EGFR Plasma RGQ PCR Kit (Qiagen). Using a digital PCR system in QIAcuity One (Qiagen) nanoplanets, the T790M mutation was analysed by digital PCR. The age of the patients ranged from 37 to 85 years.</p><p><strong>Results: </strong>Of 85 patients with NSCLC with disease progression after TKI treatment, T790M mutations were detected during digital PCR in 30 of 85 patients, which is 35.2% of the sample, and with traditional real-time PCR, positive mutations came out only in 3 out of 85 patients.</p><p><strong>Conclusions: </strong>Thus, completed study can assert that digital PCR is able to replace traditional real-time PCR as a more preferable method of high-performance quantitative determination of target nucleic acids and has a relatively high sensitivity without compromising high specificity. Results of this research also show that a liquid biopsy using digital PCR provides an opportunity to avoid repeated tissue biopsy in patients who cannot provide a tumor tissue sample suitable for molecular analysis.</p>","PeriodicalId":19851,"journal":{"name":"Panminerva medica","volume":" ","pages":"372-379"},"PeriodicalIF":4.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142351669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
One-year of pulmonologist-based teleconsultation between hospital and general practitioners: an Italian exploratory investigation. 医院与全科医生之间为期一年的基于肺科医生的远程会诊:一项意大利探索性调查。
IF 4.3 4区 医学
Panminerva medica Pub Date : 2024-12-01 Epub Date: 2024-06-11 DOI: 10.23736/S0031-0808.24.05158-9
Simone Ielo, Uberto Maccari, Raffaele Scala
{"title":"One-year of pulmonologist-based teleconsultation between hospital and general practitioners: an Italian exploratory investigation.","authors":"Simone Ielo, Uberto Maccari, Raffaele Scala","doi":"10.23736/S0031-0808.24.05158-9","DOIUrl":"10.23736/S0031-0808.24.05158-9","url":null,"abstract":"","PeriodicalId":19851,"journal":{"name":"Panminerva medica","volume":" ","pages":"444-446"},"PeriodicalIF":4.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141306511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rheumatoid arthritis: a review of the key clinical features and ongoing challenges of the disease. 类风湿性关节炎:该疾病的主要临床特征和持续挑战的综述。
IF 4.3 4区 医学
Panminerva medica Pub Date : 2024-12-01 Epub Date: 2024-12-02 DOI: 10.23736/S0031-0808.24.05272-8
Andrea DI Matteo, Paul Emery
{"title":"Rheumatoid arthritis: a review of the key clinical features and ongoing challenges of the disease.","authors":"Andrea DI Matteo, Paul Emery","doi":"10.23736/S0031-0808.24.05272-8","DOIUrl":"10.23736/S0031-0808.24.05272-8","url":null,"abstract":"<p><p>Rheumatoid arthritis (RA) is an autoimmune inflammatory condition that primarily affects the joints and periarticular soft tissue. The development of joint swelling is traditionally regarded as the starting point of the disease. Emerging evidence indicates that RA patients often experience a preclinical stage characterized by immunological and inflammatory changes before developing the disease. The review discusses ongoing efforts to predict the transition from this preclinical phase to clinical RA and describes studies aimed at preventing the onset of RA in individuals at risk. Over the past two decades, there have been significant advancements in RA management and outcomes. An increasing number of patients can now achieve disease remission, and in some cases, this remission persists without ongoing treatment, which is effectively a cure. As new therapies and evolving scientific evidence emerge, recommendations for RA management are continuously evolving. Despite these improvements in the management of RA, many patients still do not respond to multiple conventional or more advanced therapies, including biologic and targeted synthetic disease modifying anti-rheumatic drugs, or experience disease flares when treatments are tapered or discontinued. This situation underscores the need for reliable biomarkers to guide therapy more effectively, improve personalized treatment approaches and monitoring strategies (i.e. precision medicine). In conclusion, this review provides a comprehensive overview of RA, covering new research on the 'pre-clinical' phase of the disease, as well as its epidemiology, pathogenesis, clinical manifestations, diagnosis, imaging, and management strategies. It highlights key clinical aspects of RA and addresses ongoing challenges in disease management, particularly in the areas of prevention and treatment.</p>","PeriodicalId":19851,"journal":{"name":"Panminerva medica","volume":" ","pages":"427-442"},"PeriodicalIF":4.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142771335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complete versus culprit-only coronary revascularization in patients with myocardial infarction and multivessel disease undergoing percutaneous coronary intervention: an updated meta-analysis. 接受经皮冠状动脉介入治疗的心肌梗死和多支血管疾病患者接受完全冠状动脉血运重建还是仅接受罪魁祸首冠状动脉血运重建:最新荟萃分析。
IF 4.3 4区 医学
Panminerva medica Pub Date : 2024-12-01 Epub Date: 2024-11-07 DOI: 10.23736/S0031-0808.24.05267-4
Alfredo M Rodriguez-Granillo, Walter Masson, Martin Lobo, Juan Mieres, Lisandro Pérez-Valega, Leandro Barbagelata, Karen Waisten, Carlos Fernández-Pereira, Alfredo E Rodriguez
{"title":"Complete versus culprit-only coronary revascularization in patients with myocardial infarction and multivessel disease undergoing percutaneous coronary intervention: an updated meta-analysis.","authors":"Alfredo M Rodriguez-Granillo, Walter Masson, Martin Lobo, Juan Mieres, Lisandro Pérez-Valega, Leandro Barbagelata, Karen Waisten, Carlos Fernández-Pereira, Alfredo E Rodriguez","doi":"10.23736/S0031-0808.24.05267-4","DOIUrl":"10.23736/S0031-0808.24.05267-4","url":null,"abstract":"<p><strong>Introduction: </strong>Recently, the FFR-Guidance for Complete Nonculprit Revascularization (FULL REVASC) trial in ST elevation myocardial infarction (STEMI) patients with multiple vessel disease (MVD) did not show differences in the composite endpoint of death from any cause, myocardial infarction, or unplanned revascularization than culprit-lesion-only percutaneous coronary intervention (PCI) at 4.8 years, although complete revascularization is a recommendation IA in current guidelines. We want to determine through an updated meta-analysis whether complete revascularization is associated with decreased mortality and hard clinical endpoints compared to culprit lesion only PCI.</p><p><strong>Evidence acquisition: </strong>We searched MEDLINE, Embase, ISI Web of Science, and Cochrane Central Register of Controlled Trials) from January 1990 to April 2024 using the terms \"percutaneous coronary intervention\" combined with \"non culprit lesions\" or \"culprit lesion\" or \"complete revascularization\" or \"incomplete revascularization.\" Additionally, a \"snowball search\" was conducted. Only randomized clinical trials (RCT) reporting mortality, re-infarction or new revascularization after at least 12 months and using predominantly drug eluting stents were included. The summary effect of different revascularization strategies on cardiovascular endpoints was estimated and measures of effect size were expressed as odds ratios (ORs).</p><p><strong>Evidence synthesis: </strong>Eight RCT involving 9515 patients were included, with a follow-up range between 12 months and 4.8 years. Main findings show that culprit lesion revascularization was associated with an increased risk of MI (OR: 1.38; 95% CI: 1.05 to 1.81, I2 42%) and ischemia-guided revascularization (OR: 2.81; 95% CI: 1.86 to 4.26, I2 80%) compared to complete revascularization, without differences in overall mortality (OR: 1.15; 95% CI: 0.98 to 1.36, I2 2%).</p><p><strong>Conclusions: </strong>In patients with STEMI and MVD without cardiogenic shock, our metanalysis showed that complete revascularization with PCI significantly reduced the risk of non-fatal myocardial reinfarction and ischemic-driven revascularization compared to culprit vessel-only revascularization, without differences in overall mortality.</p>","PeriodicalId":19851,"journal":{"name":"Panminerva medica","volume":" ","pages":"408-416"},"PeriodicalIF":4.3,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142604054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信